Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
4.900
+0.360 (7.93%)
At close: Nov 28, 2025, 1:00 PM EST
4.960
+0.060 (1.22%)
After-hours: Nov 28, 2025, 4:18 PM EST

Vistagen Therapeutics Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
0.720.491.06-0.231.111.09
Upgrade
Revenue Growth (YoY)
-17.69%-54.32%--1.78%-
Upgrade
Gross Profit
0.720.491.06-0.231.111.09
Upgrade
Selling, General & Admin
16.9917.0814.0614.6613.967.64
Upgrade
Research & Development
49.2139.3820.0244.3834.9211.38
Upgrade
Operating Expenses
66.1956.4634.0959.0448.8919.02
Upgrade
Operating Income
-65.47-55.97-33.02-59.27-47.78-17.93
Upgrade
Interest Expense
------0.01
Upgrade
Interest & Investment Income
3.234.563.350.030.020.02
Upgrade
Other Non Operating Income (Expenses)
0.010.010.31--0
Upgrade
EBT Excluding Unusual Items
-62.24-51.41-29.36-59.24-47.76-17.93
Upgrade
Pretax Income
-62.24-51.41-29.36-59.24-47.76-17.93
Upgrade
Income Tax Expense
-0.0100.0100
Upgrade
Net Income
-62.24-51.42-29.36-59.25-47.76-17.93
Upgrade
Preferred Dividends & Other Adjustments
----0.9524.39
Upgrade
Net Income to Common
-62.24-51.42-29.36-59.25-48.71-42.32
Upgrade
Shares Outstanding (Basic)
323119773
Upgrade
Shares Outstanding (Diluted)
323119773
Upgrade
Shares Change (YoY)
7.22%59.53%178.13%5.45%129.85%96.34%
Upgrade
EPS (Basic)
-1.92-1.67-1.52-8.51-7.38-14.74
Upgrade
EPS (Diluted)
-1.92-1.67-1.52-8.51-7.38-14.74
Upgrade
Free Cash Flow
-53.16-42.29-25.87-49.93-45.46-12.35
Upgrade
Free Cash Flow Per Share
-1.64-1.37-1.34-7.17-6.89-4.30
Upgrade
Gross Margin
100.00%100.00%100.00%-100.00%100.00%
Upgrade
Operating Margin
-9080.86%-11517.08%-3103.48%--4308.68%-1646.06%
Upgrade
Profit Margin
-8631.90%-10579.83%-2759.59%--4392.42%-3884.33%
Upgrade
Free Cash Flow Margin
-7373.09%-8701.24%-2431.77%--4099.28%-1133.45%
Upgrade
EBITDA
-65.3-55.82-32.89-59.14-47.63-17.82
Upgrade
D&A For EBITDA
0.170.150.130.130.150.12
Upgrade
EBIT
-65.47-55.97-33.02-59.27-47.78-17.93
Upgrade
Revenue as Reported
0.720.491.06-0.231.111.09
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q